• ScreenPro (SCRN) will now offer concierge medical services providing home visit care beginning July 12
  • The services include medical advisory, preventive screening and corporate wellness and executive health
  • The program will begin in Vancouver with potential for future expansion
  • ScreenPro Security is a medical technology company that provides testing solutions across Canada
  • ScreenPro (SCRN) is up by 16.67 per cent and is currently trading at $0.035 per share

ScreenPro (SCRN) will now offer concierge medical services providing home visit care beginning July 12.

The program enlists accredited physicians and nurses to provide medical advisory, corporate wellness and executive health, and preventive screenings to determine the presence or absence of disease. 

The program will begin in Vancouver with potential for future expansion.

Patients will benefit from same-day appointments and direct email and phone contact with physicians.

ScreenPro’s target audience will have an initial focus on executives and corporations with large staff to keep costs low and allow for scalability.

Andrew Ryu, ScreenPro’s CEO, commented,

“When you think about the health care space in Canada in 2019 being worth $265.5 billion, and with the overall health spending representing 11.5 per cent of Canada’s gross domestic product, that is a really interesting market. We are building a health care business that has sustainability and longevity and that will add recurring high-margin revenue metrics to our existing business model.”

ScreenPro Security is a medical technology company that provides testing solutions across Canada. 

ScreenPro (SCRN) is up by 16.67 per cent and is currently trading at $0.035 per share as of 9:30 am ET.

More From The Market Online

Cancer-fighting pharma stock eyes 2027 regulatory approval

Theralase Technologies (TSXV:TLT), a cancer-fighting pharma stock, expands its team with two clinical research associates.

PharmaDrug-PharmaTher Holdings JV submits clinical, regulatory package

Sairiyo Therapeutics, a PharmaDrug (CSE:PHRX) and PharmaTher Holdings (CSE:PHRM) joint venture, pursues a human clinical study in Australia.

WELL Health and Microsoft to future-proof North American healthcare

WELL Health Technologies (TSX:WELL) and Microsoft (NDAQ:MSFT) sign a five-year deal to expedite healthcare's transition into the digital age.